SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rituparna Bhattacharya, Steve Zhou, Wenhui Wei, Mayank Ajmera, Usha Sambamoorthi, A Real-World Study of the Effect of Timing of Insulin Initiation on Outcomes in Older Medicare Beneficiaries with Type 2 Diabetes Mellitus, Journal of the American Geriatrics Society, 2015, 63, 5
  2. 2
    Jihyun Lee, New Guidelines for Elderly Diabetic Patients, The Journal of Korean Diabetes, 2015, 16, 2, 89

    CrossRef

  3. 3
    Supriya Mathur, Nicola N. Zammitt, Brian M. Frier, Optimal Glycaemic Control in Elderly People with Type 2 Diabetes: What Does the Evidence Say?, Drug Safety, 2015, 38, 1, 17

    CrossRef

  4. 4
    Steve V. Edelman, Rong Liu, Jennal Johnson, Leonard C. Glass, AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes, Diabetes Care, 2014, 37, 8, 2132

    CrossRef

  5. 5
    Philip Home, Matthew Riddle, William T. Cefalu, Clifford J. Bailey, Reinhard G. Bretzel, Stefano del Prato, Derek Leroith, Guntram Schernthaner, Luc van Gaal, Itamar Raz, Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?, Diabetes Care, 2014, 37, 6, 1499

    CrossRef

  6. 6
    B. Bauduceau, L. Bordier, J. Doucet, Les analogues lents de l’insuline : une aide pour l’insulinothérapie des sujets âgés, Médecine des Maladies Métaboliques, 2014, 8, 3, 293

    CrossRef

  7. 7
    Markku A. Vähätalo, Jorma Viikari, Tapani Rönnemaa, Starting bedtime glargine versus NPH insulin in poorly controlled type 2 diabetic patients with various hyperglycemia types (fasting type or postprandial type), Acta Diabetologica, 2014, 51, 2, 233

    CrossRef

  8. 8
    Christopher Sorli, Mark Warren, David Oyer, Henriette Mersebach, Thue Johansen, Stephen C. L. Gough, Elderly Patients with Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase IIIa Trials, Drugs & Aging, 2013, 30, 12, 1009

    CrossRef

  9. 9
    Manel Mata-Cases, Estudio observacional de eficacia y seguridad del cambio de insulina NPH a glargina en atención primaria. Estudio LAURA, Avances en Diabetología, 2013, 29, 5, 137

    CrossRef

  10. 10
    Etie Moghissi, Management of Type 2 Diabetes Mellitus in Older Patients: Current and Emerging Treatment Options, Diabetes Therapy, 2013, 4, 2, 239

    CrossRef

  11. You have free access to this content11
    G. Grunberger, The need for better insulin therapy, Diabetes, Obesity and Metabolism, 2013, 15, s1
  12. 12
    M. S. Kirkman, V. J. Briscoe, N. Clark, H. Florez, L. B. Haas, J. B. Halter, E. S. Huang, M. T. Korytkowski, M. N. Munshi, P. S. Odegard, R. E. Pratley, C. S. Swift, Diabetes in Older Adults, Diabetes Care, 2012, 35, 12, 2650

    CrossRef

  13. You have free access to this content13
    M. Sue Kirkman, Vanessa Jones Briscoe, Nathaniel Clark, Hermes Florez, Linda B. Haas, Jeffrey B. Halter, Elbert S. Huang, Mary T. Korytkowski, Medha N. Munshi, Peggy Soule Odegard, Richard E. Pratley, Carrie S. Swift, Diabetes in Older Adults: A Consensus Report, Journal of the American Geriatrics Society, 2012, 60, 12
  14. 14
    J. B. Halter, Diabetes Mellitus in an Aging Population: The Challenge Ahead, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2012, 67, 12, 1297

    CrossRef

  15. 15
    Cornelia Jaursch-Hancke, Insulinanalogon hat versus NPH-Insulin zum Teil die Nase vorn, Info Diabetologie, 2012, 6, 2, 20

    CrossRef

  16. 16
    David R Owens, Optimizing treatment strategies with insulin glargine in Type 2 diabetes, Expert Review of Endocrinology & Metabolism, 2012, 7, 4, 377

    CrossRef

  17. 17
    Flint Russett, Recent Publications on Medications and Pharmacy, Hospital Pharmacy, 2012, 47, 3, 245

    CrossRef